Does the Underlying Haemodynamic Abnormality Determine Response to Antihypertensive Therapy.
Phase of Trial: Phase IV
Latest Information Update: 08 Aug 2016
At a glance
- Drugs Bisoprolol (Primary) ; Candesartan cilexetil (Primary) ; Doxazosin (Primary) ; Isosorbide mononitrate (Primary)
- Indications Cardiovascular disorders; Hypertension
- Focus Therapeutic Use
- Acronyms ROTATION
- 31 May 2012 United Kingdom Clinical Research Network reports accrual to date changed from 20% to 23%.
- 31 May 2012 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network.
- 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.